Home › Funds › Paul R. Ried Financial Group, LLC › JNJ

Paul R. Ried Financial Group, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Paul R. Ried Financial Group, LLC reported holding 967 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$256K, representing 0.10% of its reported portfolio and ranking #41 among its reported holdings. Paul R. Ried Financial Group, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)967 sh
Reported value held$255.97K
Portfolio Weight0.10%
First reportedQ4 2025
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Paul R. Ried Financial Group, LLC's JNJ position evolved

Paul R. Ried Financial Group, LLC first disclosed a stake in JNJ in Q4 2025 at 1,192 shares (US$247K). The position peaked in Q1 2026 at 1,187 shares, worth US$290K. Across 4 filings, Paul R. Ried Financial Group, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 967 shares valued at US$256K — a reduction of -139 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.19K $246.83K New
Q1 2026 1.19K $290.26K Hold
Q2 2026 1.11K $280.97K Reduce
Q3 2026 967 $255.97K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Paul R. Ried Financial Group, LLC held JNJ?

Paul R. Ried Financial Group, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Paul R. Ried Financial Group, LLC's current position in JNJ?

As of Q3 2026, Paul R. Ried Financial Group, LLC holds 967 shares of JNJ (JOHNSON & JOHNSON), valued at $255.97K, representing 0.10% of its reported portfolio and ranking #41.

Has Paul R. Ried Financial Group, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Paul R. Ried Financial Group, LLC reduced its position in JNJ. The position peaked in Q1 2026 at 1.19K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.